2022 Canadian Leadership Council on Drug Plan Partnerships

The 2022 Canadian Leadership Council on Drug Plan Partnerships brought together benefit plan advisors to discuss innovation in drug development and its impact on Canadian private drug plans. Although many drug innovations have been life-changing, plan advisors are concerned about the impact on their clients’ benefit plans. Unfortunately, the lack of effective insurance often leaves plan sponsors no choice but to restrict or reduce coverage to manage their risk. Click below to read the full coverage.

Sponsors